Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Lung Neoplasms 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

X-Rays 2Standard of Care 2Bronchoscopy 2vilanterol 1perflutren 1Surgical Procedures, Operative 1Sulfur Hexafluoride 1Sulfonylurea Compounds 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Singing 1Rehabilitation 1Pulmonary Surgical Procedures 1Iloprost 1Hematologic Tests 1Educational Status 1Drug Delivery Systems 1Dipeptidyl-Peptidase IV Inhibitors 1CIMAvax EGF 1Budesonide 1Bronchoalveolar Lavage 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Disease, Chronic Obstructive × Sulfonylurea Compounds × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡